This product is supplied strictly for research purposes only and is not intended for human consumption
Rarely a client will have itching, redness, or occasional bruising at the site of injection
| Protocol Type | Tirzepatide Dose | 5-Amino-1MQ Dose | Administration Frequency | Expected Mechanism | Typical Observation Window | Professional Assessment | ||||||| | Tirzepatide Monotherapy | 2.515mg weekly (titrated) | None | Weekly subcutaneous injection | GLP-1/GIP receptor agonism reduces appetite and slows gastric emptying | 1220 weeks to plateau | Proven efficacy in human trials
These injections are particularly useful in people with absorption problems or restrictive diets
The COA lists the compound name, CAS number, lot number, analytical methods used (HPLC, LCMS), and the measured purity percentage
Vitamin B12 Hydroxocobalamin Neo-Cytamen 5x1ml